Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9329 |
High Similarity |
NPD3882 |
Suspended |
0.9133 |
High Similarity |
NPD3817 |
Phase 2 |
0.8896 |
High Similarity |
NPD5494 |
Approved |
0.8846 |
High Similarity |
NPD3926 |
Phase 2 |
0.8844 |
High Similarity |
NPD6799 |
Approved |
0.8839 |
High Similarity |
NPD1247 |
Approved |
0.8831 |
High Similarity |
NPD919 |
Approved |
0.8816 |
High Similarity |
NPD2801 |
Approved |
0.875 |
High Similarity |
NPD1934 |
Approved |
0.8725 |
High Similarity |
NPD1512 |
Approved |
0.8621 |
High Similarity |
NPD2796 |
Approved |
0.8591 |
High Similarity |
NPD1511 |
Approved |
0.8571 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD6166 |
Phase 2 |
0.8533 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8497 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8452 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8447 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8421 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8293 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8291 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8269 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8242 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8193 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8165 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8151 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8133 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8121 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8121 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8101 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8079 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8067 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8065 |
Intermediate Similarity |
NPD920 |
Approved |
0.8065 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8054 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8052 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8041 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8025 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7973 |
Intermediate Similarity |
NPD1933 |
Approved |
0.795 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7935 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7922 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7862 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7852 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7844 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7818 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7785 |
Intermediate Similarity |
NPD943 |
Approved |
0.7778 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7755 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7751 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7727 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7716 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7706 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.766 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7605 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7597 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7595 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7595 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7595 |
Intermediate Similarity |
NPD2532 |
Approved |
0.759 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7531 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7531 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5353 |
Approved |
0.75 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7471 |
Intermediate Similarity |
NPD2163 |
Approved |
0.7471 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7456 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.745 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7405 |
Intermediate Similarity |
NPD2309 |
Approved |
0.74 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7349 |
Intermediate Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7347 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7315 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7303 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7297 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7297 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7297 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7273 |
Intermediate Similarity |
NPD37 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD17 |
Approved |
0.7257 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7246 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7241 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7228 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7205 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7197 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7191 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7169 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7169 |
Intermediate Similarity |
NPD6279 |
Approved |
0.716 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7127 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7086 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7078 |
Intermediate Similarity |
NPD411 |
Approved |
0.7078 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7069 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7035 |
Intermediate Similarity |
NPD5710 |
Approved |
0.703 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7025 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7017 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.6994 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6987 |
Remote Similarity |
NPD3140 |
Approved |
0.6987 |
Remote Similarity |
NPD3142 |
Approved |
0.6982 |
Remote Similarity |
NPD5977 |
Approved |
0.6982 |
Remote Similarity |
NPD5978 |
Approved |
0.6981 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6968 |
Remote Similarity |
NPD3268 |
Approved |
0.6968 |
Remote Similarity |
NPD5005 |
Approved |
0.6968 |
Remote Similarity |
NPD5006 |
Approved |
0.6964 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6959 |
Remote Similarity |
NPD9268 |
Approved |
0.6951 |
Remote Similarity |
NPD4662 |
Approved |
0.6951 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD4661 |
Approved |
0.6948 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6937 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6933 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6923 |
Remote Similarity |
NPD4585 |
Approved |
0.6923 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6918 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6914 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.691
|
Remote Similarity |
NPD7685 |
Pre-registration |